Skip to main content
[Preprint]. 2021 Apr 16:2021.04.07.21255089. Originally published 2021 Apr 10. [Version 2] doi: 10.1101/2021.04.07.21255089

Figure 1.

Figure 1.

Doses of CCP distributed in the United States by the American Red Cross and American Blood Centers (dashed) and total COVID-19 cases in the United States reported in OWID (solid). The vertical black line marks August 23, 2020 when the FDA announced that Emergency Use Authorization for CCP in the USA. The vertical gray line marks April 4, 2020 as the start of the Emergency Access Program.